253 results
Page 4 of 13
8-K
EX-10.1
zo37y
10 Feb 14
Proceeds support BDSI’s complete execution of anticipated 2014 commercial launch plans for BUNAVAIL™ and funding of Clonidine Topical Gel NDA program
12:00am
8-K
EX-10.1
s04pte futcotcerpu
23 Oct 13
BioDelivery Sciences Appoints Ernest De Paolantonio
12:00am
8-K
EX-10.1
gr4s8pgl m3mfn
11 Jul 13
BioDelivery Sciences Adds $20 Million with Debt Financing
12:00am
8-K
EX-10.1
5e42r1tih265n9
1 Apr 13
BioDelivery Sciences Expands Product Pipeline with Acquisition of
12:00am
8-K
EX-10.1
qxizs 946t79
28 Nov 12
BioDelivery Sciences Announces $40 Million Registered Financing
12:00am
8-K
EX-10.1
x7j83k11 qybq20ov9l
19 Sep 12
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
iwvnzegw kuralyn3r
11 Jan 12
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
12:00am
8-K
EX-10.1
bjn ly43fb6
13 May 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
nxbwd bt8oh9uqamog
16 Mar 11
BioDelivery Sciences Announces Business Update Call Following Pricing of
12:00am
8-K
EX-10.1
asyirvmfj2 zjos
8 Oct 10
Commercial Partnership for BEMA Fentanyl in Taiwan
12:00am
8-K
EX-10.1
ktxslzo15im05dith
7 Sep 10
BioDelivery Sciences Adds New Executive
12:00am
8-K
EX-10.2
p43ebku6sja2z2 vx
7 Sep 10
BioDelivery Sciences Adds New Executive
12:00am
8-K
EX-10.1
y8xwrf 5vj
27 May 10
Commercial Partnership for BEMA Fentanyl in South Korea
12:00am
8-K
EX-10.1
6w873y44p 70dd68b
20 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
x3d48zcw9olae06u
31 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
3rvlr
31 Dec 09
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
th1nk12y
31 Dec 09
Entry into a Material Definitive Agreement
12:00am